Atlas Trials

A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Clinical trial NCT01675531 · COMPLETED

Trial details

NCT number
NCT01675531
Sponsor
Mundipharma Korea Ltd
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cancer
Start date
2012-12-01
Primary completion
2013-12-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.